Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.
Numakura K, Sekine Y, Hatakeyama S, Muto Y, Sobu R, Kobayashi M, Sasagawa H, Kashima S, Yamamto R, Nara T, Akashi H, Tabata R, Sato S, Saito M, Narita S, Ohyama C, Habuchi T.
Numakura K, et al. Among authors: sato s.
Cancer Med. 2023 Aug;12(16):16837-16845. doi: 10.1002/cam4.6306. Epub 2023 Jul 5.
Cancer Med. 2023.
PMID: 37403728
Free PMC article.